RNA Transcriptomics Market Size to Reach USD 12.46 Billion in 2028 Growing at a CAGR of 13.6%, according to Emergen Research
Emergen Research has published its latest report titled “RNA Transcriptomics Market, By Product Type (Reagents, Instruments, Software, Services), By Technology (Microarrays, Polymerase Chain Reaction, RNA Sequencing, RNA Interference), By Application (Clinical Diagnostics, Toxicogenomics, Drug Discovery & Development, Comparative Transcriptomics), By End-use (Hospitals, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations), and By Region, Forecast to 2028”
According to Emergen Research, the global RNA transcriptomics market size was USD 4.46 Billion in 2020 and is expected to reach USD 12.46 Billion in 2028 and register a revenue CAGR of 13.6% during the forecast period, 2021-2028.
Key factors supporting revenue growth of the global RNA transcriptomics market are growing demand for precision medicine, increasing applications of RNA transcriptomics in gene expression studies, rising focus on studying gene mutations in cancer genes and genetic variations, and increasing government investments in pharmaceutical and biotechnological research & development activities. Transcriptomics refers to the analysis of RNA transcriptomes present in an individual cell using high-throughput techniques. It is an integral part of gene expression studies, and it examines all elements of mRNA, non-coding RNA, and microRNA transcripts.
Transcriptomics helps in the identification of the transcriptional structure of genes, as well as assessment of the changing behavior of RNA transcripts at different development stages. Hence, the identification and quantification processes depend on the RNA expression levels, functions, locations, and degradation. Various techniques used in RNA transcriptomics include RNA sequencing, RNA interference, microarrays, real-time polymerase chain reaction (RT-PCR), and expressed sequence tag (EST)-based methods. Increasing focus on developing novel clinical biomarkers, rising need for better understanding of gene-to-drug interactions, and increasing applications of transcriptomic technologies in new drug development further boost the global RNA transcriptomics market revenue growth.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/610
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Reagents Segment Accounted for Largest Revenue Share in 2020:
Based on product type, the global RNA transcriptomics market is segmented into reagents, instruments, software, and services. The reagents segment accounted for the largest revenue share in the global market in 2020, mainly owing to factors such as increasing use of reagents in techniques including RNA sequencing, real-time polymerase chain reaction (RT-PCR), and microarrays, and growing demand for high-performance reagents.
Drug Discovery & Development Segment to Account for Fastest Revenue CAGR:
In terms of application, the global RNA transcriptomics market is segmented into clinical diagnostics, toxicogenomics, drug discovery & development, and comparative transcriptomics. The drug discovery & development segment is projected to register the fastest revenue growth rate in the global market over the forecast period. Increasing applications of RNA transcriptomics in drug discovery and development projects is a key factor boosting this segment’s revenue growth.
North America Market Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America RNA transcriptomics market was the most dominant in terms of largest revenue share in the global market in 2020. Rise in genomic and proteomic research & development activities, increasing government investments in the pharmaceutical and biotechnology sectors, rising demand for structure-based drug designs, and increasing focus on novel drug discovery & development are key factors contributing to the North America market revenue growth.
Buy your Exclusive copy@ https://www.emergenresearch.com/select-license/610
Major Companies in the Global RNA Transcriptomics Market Include:
- Thermo Fisher Scientific
- Bio-Rad Laboratories, Inc
- Merck KGaA
- Agilent Technologies, Inc.
- Illumina, Inc.
- GenXPro GmbH
- Fluidigm Corporation
- CD Genomics
- Sequentia Biotech SL
For the purpose of this report, Emergen Research has segmented the global RNA transcriptomics market based on product type, technology, application, end-use, and region:
Product Type Outlook (Revenue: USD Billion; 2018–2028)
Technology Outlook (Revenue: USD Billion; 2018–2028)
- Polymerase Chain Reaction
- RNA Sequencing
- RNA Interference
Application Outlook (Revenue: USD Billion; 2018–2028)
- Clinical Diagnostics
- Drug Discovery & Development
- Comparative Transcriptomics
End-use Outlook (Revenue: USD Billion; 2018–2028)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
Region Outlook (Revenue, USD Billion; 2018-2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Bioremediation Market Projected To Be Worth USD 334.70 Billion By 2027 Growing at a CAGR of 15.5% | Emergen Research
Cancer Imaging Systems Market To Reach USD 12.24 Billion by 2027 | Emergen Research
Intelligent Drug Discovery Market Size To Be Worth USD 3,711.8 Million by 2027 | Emergen Research
AI-Enabled Medical Imaging Solutions Market Size To Be Worth USD 4,720.6 Million by 2027 | Emergen Research
Prenatal Testing and Newborn Screening Market Size To Be Worth USD 10.85 Billion by 2027 | Emergen Research
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Full Press Release@ https://www.emergenresearch.com/press-release/global-rna-transcriptomics-market